Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.
- HAZ Height-for-age z score LTFU Long-term follow-up PEG-IFN Peginterferon RBV Ribavirin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health